Analyst Price Targets — PSNL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 24, 2026 12:55 pm | — | Craig-Hallum | $16.25 | $17.22 | TheFly | Personalis downgraded to Hold from Buy at Craig-Hallum |
| July 21, 2026 10:35 am | — | BTIG | $16.25 | $13.34 | TheFly | Personalis price target raised to $16.25 from $11 at BTIG |
| July 20, 2026 2:08 pm | Thomas Flaten | Lake Street | $16.25 | $13.16 | TheFly | Personalis downgraded to Hold from Buy at Lake Street |
| July 17, 2026 10:50 am | — | Needham | $17.00 | $15.58 | StreetInsider | Personalis (PSNL) PT Raised to $17 at NeedhamMember Login |
| May 12, 2026 12:32 pm | — | Morgan Stanley | $9.00 | $5.93 | TheFly | Personalis price target lowered to $9 from $10 at Morgan Stanley |
| May 11, 2026 11:15 am | Mark Massaro | BTIG | $11.00 | $5.98 | TheFly | Personalis price target lowered to $11 from $13 at BTIG |
| January 26, 2026 2:35 pm | Subbu Nambi | Guggenheim | $13.00 | $10.53 | TheFly | Personalis price target raised to $13 from $12 at Guggenheim |
| December 1, 2025 9:33 pm | Kallum Titchmarsh | Morgan Stanley | $11.00 | $9.68 | TheFly | Personalis assumed with an Equal Weight at Morgan Stanley |
| November 5, 2025 1:50 pm | Thomas Flaten | Lake Street | $11.00 | $8.25 | TheFly | Personalis price target raised to $11 from $9 at Lake Street |
| November 5, 2025 11:16 am | Mike Matson | Needham | $10.00 | $8.73 | StreetInsider | Personalis (PSNL) PT Raised to $10 at Needham |
Latest News for PSNL
Personalis, Inc. (NASDAQ: PSNL - Get Free Report) has been assigned an average rating of "Hold" from the ten ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to
Personalis (PSNL) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.23 per share a year ago.
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the second quarter ended June 30, 2026, and highlighted recent business accomplishments. Second Quarter and Recent Strategic and Operational Highlights Secured Medicare Coverage for IO Monitoring: Received Medicare coverage approval for NeXT…
MONSEY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Monsey law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Personalis, Inc. (Nasdaq: PSNL) (“Personalis”) to Tempus AI, Inc. (“Tempus”) for $16.25 per share.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PSNL.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.